Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21497999 | 0.98 | KDM4E (0.32) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL13267202 | 0.91 | KDM4E (0.33) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL18951633 | 0.88 | KDM4E (0.31) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL14037002 | 0.87 | KDM4E (0.40) | KDM4ELMNAMAPTATML3MBTL1 | |
| SCHEMBL10039123 | 0.86 | KDM4E (0.31) | KDM4EATML3MBTL1 | |
| SCHEMBL13113025 | 0.84 | KDM4E (0.31) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL125237 | 0.84 | KDM4E (0.43) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL12653898 | 0.82 | KDM4E (0.31) | KDM4EATML3MBTL1 | |
| SCHEMBL23739395 | 0.82 | KDM4E (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL13179395 | 0.81 | KDM4E (0.37) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309376-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
| EP-3591728-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2022-12-14 | — | — | EP | disclosed |
| EP-3637490-B1 | HIGH EFFICIENCY YELLOW LIGHT EMITTERS FOR OLED DEVICES | UNIVERSAL DISPLAY CORP (US) | 2021-04-21 | — | — | EP | disclosed |
| EP-3470494-A1 | OLED COMPRISING ORGANIC COMPOUNDS CONTAINING B-N HETEROCYCLES | Universal Display Corporation (US) | 2019-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230309376-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, PDCD1LG2, NECTIN4 | KDM4E 2475/4885MEN1 2086/4885LMNA 4228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.